Skip to main content

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Recently Announced (Pending Confirmation)

Provisional data. These recalls were reported on FDA's own recall-announcement page but haven't yet been confirmed against openFDA's structured Drug Enforcement data. Public Health Trace is not affiliated with the FDA; this is not an official enforcement record until confirmed.
FDA Announcement

Par Health USA, LLC

Argatroban Injection 250 mg/2.5 mL (100 mg/mL)

Presence of particulate matter, identified as cellulose, polystyrene, polyethylene terephthalate, stopper material, and possibly stainless steel

Announced October 14, 2026 · View FDA announcement

FDA Announcement

Par Health

Brevital Sodium 500 mg/vial for Injection

Presence of particulate matter identified as cellulose

Announced October 9, 2026 · View FDA announcement

FDA Announcement

Greenwich Rx

Glutathione Injection

Potential elevated endotoxin levels

Announced October 1, 2026 · View FDA announcement

FDA Announcement

Otsuka ICU Medical LLC

0.9% Sodium Chloride Injection, USP, 100 mL

Product mix-up where 0.9% Sodium Chloride Injection, USP overwrap may contain 10 mEq Potassium Chloride Injection

Announced September 21, 2026 · View FDA announcement

FDA Announcement

Par Health

Dexmedetomidine HCl in 0.9% Sodium Chloride Injection 400 mcg/100 mL (4 mcg/mL) for Intravenous Infusion

Presence of particulate matter identified as cellulose or stopper material

Announced September 21, 2026 · View FDA announcement

FDA Announcement

Centric Compounding LLC

Compounded Glutathione 200 mg/mL 30 mL multidose vial; Myer’s Cocktail 30 mL multidose vial; Tri-Immune Boost 30 mL multidose vial

Elevated Endotoxin level

Announced September 13, 2026 · View FDA announcement

FDA Announcement

B. Braun Medical Inc.

0.9% Sodium Chloride Injection USP, 100 mL, in a 150 mL PAB® Container

Presence of particulate matter identified as iron oxide

Announced September 3, 2026 · View FDA announcement

FDA Announcement

Ana Salazar Modela Tu Cuerpo Inc.

Lipofit Extreme 2.0 Fat Burner Dietary Supplement

Undeclared Fluoxetine and 2,4-Dinitrophenol (DNP)

Announced August 31, 2026 · View FDA announcement

FDA Announcement

Baxter International Inc.

0.9% Sodium Chloride Injection, USP, 500 mL VIAFLEX Plastic Container

Potential presence of particulate matter identified as fiberglass in the solution.

Announced August 26, 2026 · View FDA announcement

FDA Announcement

Baxter International Inc.

70% Dextrose Injection, USP in 2000 mL VIAFLEX Plastic Container

Potential presence of particulate matter identified as stainless steel particles in the solution.

Announced August 25, 2026 · View FDA announcement

FDA Announcement

Baxter International Inc.

Anticoagulant Sodium Citrate Solution USP, 250 mL VIAFLEX Plastic Container

Potential presence of particulate matter identified as fiberglass in the solution

Announced August 25, 2026 · View FDA announcement

FDA Announcement

Vitruvias Therapeutics, Inc

Thyroid Tablets, USP 30 mg

Potential for the Product to be Superpotent

Announced August 24, 2026 · View FDA announcement

FDA Announcement

Optimal Balance Pharmacy

Glutathione Injection 200MG/ML (30ML), Multi-Dose Vial

Elevated Endotoxin level

Announced August 20, 2026 · View FDA announcement

FDA Announcement

B. Braun

Excel® Lactated Ringers Injection, 1000mL

Presence of particulate matter identified primarily as cellulose cotton fibers, with individual particles also identified as cellulose wood fiber and polystyrene

Announced August 19, 2026 · View FDA announcement

FDA Announcement

Fresenius Kabi

Tyenne Injection 400 mg/20 mL vial

Due to Presence of Glass Particles

Announced August 11, 2026 · View FDA announcement

FDA Announcement

Fresenius Kabi

Morphine Sulfate Injection USP, Simplist® 2 mg/1 mL

Due to a label mix-up

Announced August 5, 2026 · View FDA announcement

FDA Announcement

Victory Medical Center Pharmacy

Compounded Glutathione 200 mg/mL Multi-Dose Vials

Elevated Endotoxin level

Announced August 5, 2026 · View FDA announcement

FDA Announcement

Liebel-Flarsheim Company, LLC

OPTIRAY Imaging Bulk Package (IBP) 350, 500mL in vial (Ioversol Injection 74% 350 mg iodine/ml)

Presence of particulate matter comprising polyethylene and other plastic materials, stainless steel and glass

Announced August 4, 2026 · View FDA announcement

FDA Announcement

American Regent, Inc. Animal Health

Adequan Canine Injection and Adequan i.m Injection for horses

Visible glass fiber material in the product

Announced August 3, 2026 · View FDA announcement

FDA Announcement

American Regent, Inc.

Papaverine Hydrochloride Injection, USP 60 mg/ 2 mL

Products were found to contain particulate matter

Announced July 27, 2026 · View FDA announcement

FDA Announcement

Sunny Pharmtech, Inc.

Cyclophosphamide for Injection

Presence of particulate matter identified as steel

Announced July 24, 2026 · View FDA announcement

FDA Announcement

Baxter International Inc.

Cefazolin in Dextrose Injection

Particulate matter (cardboard) found in the solution.

Announced July 24, 2026 · View FDA announcement

FDA Announcement

Unique Pharmaceutical Laboratories

Cetirizine Hydrochloride Tablets USP 5 mg

Potential cross contamination with Ranitidine

Announced July 20, 2026 · View FDA announcement

FDA Announcement

Beekeeper’s Naturals

Saline Nasal Spray

Above acceptable microbiological limits for yeast and may contain Aspergillus spp.

Announced June 12, 2026 · View FDA announcement

FDA Announcement

BD

ChloraPrep Clear – 1 mL Applicators and ChloraPrep FREPP Clear 1.5 mL Applicators

Potential fungal contamination under certain environmental conditions allowing the growth of Aspergillus penicillioides

Announced June 8, 2026 · View FDA announcement

FDA Announcement

Haleon

Gass-X Extra Strength Softgels 120 and 72ct

Potential chemical contamination

Announced June 4, 2026 · View FDA announcement

FDA Announcement

Sun Pharmaceutical Industries, Inc.

DOXOrubicin Hydrochloride Liposome Injection 50mg/25 mL

Presence of glass particles

Announced May 13, 2026 · View FDA announcement

FDA Announcement

Pharmacal

Multi-symptom Treatment Cream & Skin Protectant Eczema Cream, 6oz tube

Contaminated with Staphylococcus aureus.

Announced May 12, 2026 · View FDA announcement

FDA Announcement

B. Braun Medical Inc.

Lactated Ringer's Injection, E7500, 1L

Products were found to contain particulate matter in solution

Announced April 28, 2026 · View FDA announcement

FDA Announcement

Blaine Labs, Inc.

Antiseptic wound care gel bottles and tubes

Products were found to contain Lysinibacillus fusiformis, an environmental organism

Announced April 8, 2026 · View FDA announcement

FDA Announcement

Aphreseller

Dietary supplement capsules marketed for treatment for gaining weight and stimulating appetite.

Device & Drug Safety/Unapproved Drug

Announced April 1, 2026 · View FDA announcement

FDA Announcement

Amneal Pharmaceuticals LLC

Magnesium Sulfate in Water for Injection, USP, 4g/100mL, IV bag

A Magnesium Sulfate in Water for Injection pouch was found to contain an IV bag of Tranexamic Acid in 0.7% Sodium Chloride Injection, 10 mg/mL.

Announced March 24, 2026 · View FDA announcement

FDA Announcement

Cardinal Health

Large Alcohol Prep Pads (70% isopropyl alcohol)

Microbial Contamination

Announced March 20, 2026 · View FDA announcement

FDA Announcement

Anthony Trinh, 123Herbals LLC

Dietary supplement capsules marketed for relief of joint and body aches

Unapproved new drug found to contain undeclared meloxicam

Announced January 9, 2026 · View FDA announcement

FDA Announcement

Modern Warrior

Dietary supplement capsules marketed for metabolism moosting, improving brain function, and reducing cravings

Unapproved new drug found to contain undeclared 1,4-DMAA and aniracetam, and tianeptine

Announced January 9, 2026 · View FDA announcement

FDA Announcement

Gold Star Distribution, Inc.

All FDA-regulated products held at facility including drugs, medical devices, cosmetics, dietary supplements, human food, and pet food

Potential Salmonella contamination, presence of rodent and avian contamination and insanitary conditions during the storage process.

Announced December 26, 2025 · View FDA announcement

FDA Announcement

Handelnine Global Limited d/b/a Navafresh

Rheumacare Capsules

Elevated levels of lead

Announced December 22, 2025 · View FDA announcement

FDA Announcement

StuffbyNainax LLC

Dietary supplement for male enhancement

Undeclared Sildenafil and Tadalafil

Announced December 16, 2025 · View FDA announcement

FDA Announcement

MediNatura New Mexico Inc.

Nasal spray, 0.68 fl oz

Product has been found to contain yeast/mold and microbial contamination with one species identified as Achromobacter, at levels above specifications.

Announced December 16, 2025 · View FDA announcement

FDA Announcement

MediNatura New Mexico Inc.

Nasal spray, 0.68 fl oz

Product has been found to contain yeast/mold and microbial contamination with one species identified as Achromobacter, at levels above specifications.

Announced December 10, 2025 · View FDA announcement

FDA Announcement

Fresenius Kabi USA, LLC

Famotidine Injection, USP 20 mg per 2 mL

Out-of-specification endotoxin results

Announced November 7, 2025 · View FDA announcement

FDA Announcement

Otsuka ICU Medical LLC

20 mEq Potassium Chloride Injection

Potential for Potassium chloride overdose: 20 mEq Potassium Chloride Injection is Mislabeled As 10 mEq Potassium Chloride Injection

Announced November 3, 2025 · View FDA announcement

FDA Announcement

Green Lumber Holding, LLC.

Dietary Supplement

Undeclared prescription drug-Tadalafil

Announced August 29, 2025 · View FDA announcement

FDA Announcement

DermaRite Industries

Hand Sanitizers, Cleansers, Skin Protectants, Deodorant

Device & Drug Safety - Potential Burkholderia cepacia contamination

Announced August 28, 2025 · View FDA announcement

FDA Announcement

Unichem Pharmaceuticals

Cyclobenzaprine Hydrochloride Tablets USP 10 mg

Device & Drug Safety – Mislabel

Announced August 27, 2025 · View FDA announcement

FDA Announcement

B. Braun Medical, Inc.

Lactated Ringer’s Injection USP 1000 mL/0.9% Sodium Chloride Injection USP 1000 mL

Due to the presence of particulate matter.

Announced August 19, 2025 · View FDA announcement

FDA Announcement

DermaRite Industries, LL

OTC antiseptic lotion soaps, external analgesics, antimicrobial foam soaps, and antiseptic cleansers

Contamination with Burkholderia cepacia

Announced August 9, 2025 · View FDA announcement

FDA Announcement

Nostrum Laboratories, Inc.

Sucralfate Tablets USP 1 gram

Company closure and discontinuation of quality activities.

Announced July 14, 2025 · View FDA announcement

FDA Announcement

Sandoz Inc.

Cefazolin for Injection, USP, 1 gm vial

Potential Presence of Penicillin G Potassium Injection Vial

Announced June 27, 2025 · View FDA announcement

FDA Announcement

Church & Dwight Co., Inc.

Cold Remedy Nasal Swabs, Nasal AllClear Swabs, Baby Teething Swabs

Microbial contamination

Announced June 6, 2025 · View FDA announcement

FDA Announcement

Amneal Pharmaceutical LLC

Sulfamethoxazole/Trimethoprim Tablets, USP, 400 mg/80 mg

Microbial contamination

Announced June 4, 2025 · View FDA announcement

FDA Announcement

UMARY USA

Unavy Acidio Hialuronico (30 caplets/850 mg) and Umovy Acidio Hialuronico (30 caplets/850 mg)

The product contains undeclared Dexamethasone, Diclofenac and Omeprazole

Announced May 22, 2025 · View FDA announcement

FDA Announcement

EnShiShiXiangNiShangMaoYouXianGongSi

Dietary supplement for male performance and energy

Undeclared Propoxyphenylsildenafil, Sildenafil

Announced May 6, 2025 · View FDA announcement

FDA Announcement

Amneal Pharmaceuticals LLC.

Ropivacaine Hydrochloride Injection, USP, 500mg/100mL IV bag

Product may contain an inert fiber identified as polypropylene fibers from the IV bag

Announced April 18, 2025 · View FDA announcement

FDA Announcement

CAPS

Phenylephrine 40 mg added to 0.9% Sodium Chloride 250 mL in 250 mL Excel Bag

Due to visible black particulate matter

Announced February 25, 2025 · View FDA announcement

FDA Announcement

Ascent Consumer Products Inc.

Soft Tip Squeeze Bottle Nasal Wash System

Microbial contamination of the product with Staphylococcus aureus (S. aureus)

Announced February 25, 2025 · View FDA announcement

FDA Announcement

One Source Nutrition

Vitality male enhancement dietary supplement capsules

Undeclared Sildenafil and Tadalafil

Announced February 20, 2025 · View FDA announcement

FDA Announcement

BD

ChloraPrep Clear 1 mL applicator skin preparation product

Potential for fungal contamination under certain environmental conditions allowing the growth of Aspergillus penicillioides

Announced February 18, 2025 · View FDA announcement

FDA Announcement

ICU Medical

POTASSIUM CHLORIDE Inj. 20 mEq and 10 mEq

Bags of POTASSIUM CHLORIDE Inj. 20 mEq have incorrect overwrap labels which state POTASSIUM CHLORIDE Inj. 10 mEq.

Announced February 14, 2025 · View FDA announcement

FDA Announcement

Alvogen, Inc.

Fentanyl Transdermal System 25 mcg/h transdermal patches

There is potential that patches could be multi-stacked, adhered one on top of the other, in a single product pouch

Announced January 31, 2025 · View FDA announcement

FDA Announcement

Provepharm Inc.

Phenylephrine hydrochloride Injection, USP, 10 mg/ mL

Device & Drug Safety – Potential Foreign Material

Announced January 24, 2025 · View FDA announcement

FDA Announcement

Astellas Pharma US, Inc.

Tacrolimus and Tacrolimus Extended-Release capsules

Bottles may contain empty capsules.

Announced December 24, 2024 · View FDA announcement

FDA Announcement

Alcon Laboratories

Lubricant Eye Drugs

Due to Fungal Contamination

Announced December 23, 2024 · View FDA announcement

FDA Announcement

Endo, Inc.

Adrenalin® Chloride Solution (EPINEPHrine nasal solution, USP)

Product is an unapproved drug.

Announced December 20, 2024 · View FDA announcement

FDA Announcement

Shoppers-Plaza

SugarLin Herbal Formula Herbal Dietary Supplement

Product contains undeclared Metformin and Glyburide

Announced December 18, 2024 · View FDA announcement

FDA Announcement

Buy-herbal.com

Nhan Sam Tuyet Lien Truy Phong Hoan dietary supplement capsules

Device & Drug Safety – Unapproved Drug

Announced December 13, 2024 · View FDA announcement

FDA Announcement

MXBBB

UMARY Hyaluronic Acid tablets

The product contains undeclared diclofenac and omeprazole

Announced November 21, 2024 · View FDA announcement

FDA AnnouncementTerminated

Endo, Inc.

Clonazepam Orally Disintegrating Tablets, USP (C-IV)

Mislabeled with the incorrect strength on the carton

Announced November 19, 2024 · View FDA announcement

FDA Announcement

VitalityVita

Marketed as Dietary Supplement

Undeclared Sildenafil and Diclofenac

Announced November 6, 2024 · View FDA announcement

FDA Announcement

Boulla LLC

Marketed as Dietary Supplement

Undeclared Sildenafil and Diclofenac

Announced November 5, 2024 · View FDA announcement

FDA Announcement

C&A Naturistics

AK Forte Dietary Supplement

Device & Drug Safety – Unapproved Drug

Announced October 16, 2024 · View FDA announcement

FDA Announcement

STASKA Pharmaceuticals Inc.

Ascorbic Acid Solution for Injection

Device & Drug Safety – Presence of glass particulates

Announced October 16, 2024 · View FDA announcement

FDA AnnouncementTerminated

Gilead Sciences, Inc.

Veklury (remdesivir) for Injection

Due to Presence of Glass Particle

Announced September 23, 2024 · View FDA announcement

FDA Announcement

Bionpharma Inc.

Atovaquone Oral Suspension, 750 mg/mL

Product found to be contaminated with Cohnella bacteria

Announced September 18, 2024 · View FDA announcement

FDA Announcement

B. Braun Medical Inc.

0.9% Sodium Chloride for Injection USP 1000 mL in E3 containers

Potential for particulate matter and fluid leakage of the containers

Announced August 8, 2024 · View FDA announcement

FDA Announcement

Baxter International Inc

Heparin Sodium in 0.9% Sodium Chloride Injection

Elevated endotoxin levels

Announced August 6, 2024 · View FDA announcement

FDA Announcement

Aurobindo Pharma USA, Inc.

Migraine Relief Acetaminophen 250mg, Aspirin (NSAID) 250mg & Caffeine 65mg tablets

Device & Drug Safety - Mislabeling

Announced July 24, 2024 · View FDA announcement

FDA Announcement

Main Products, Inc.

Umary Acido Hialuronico, Suplemento Alimenticio

Undeclared Drug Ingredients: Diclofenac and Omeprazole

Announced July 22, 2024 · View FDA announcement

FDA Announcement

Hikma Pharmaceuticals PLC

Acetaminophen Injection 1,000 mg per 100 mL (10 mg/mL) 100 mL

Potential presence of Dexmedetomidine HCL Injection (400mcg/100mL) inside the overwrap that is labelled Acetaminophen Injection, 1000mg/100mL, (10mg/mL).

Announced July 22, 2024 · View FDA announcement

FDA Announcement

Endo USA, Inc

Clonazepam Orally Disintegrating Tablets, USP (C-IV) 0.25 mg tablets

Mislabeled with the incorrect strength on the carton

Announced July 17, 2024 · View FDA announcement

FDA Announcement

Guru Inc.

Infla-650 Herbal Dietary Supplement Capsules

Tainted with the drug ingredients: acetaminophen, diclofenac and phenylbutazone

Announced July 16, 2024 · View FDA announcement

FDA Announcement

SoloVital.com

Umary Acido Hialuronica, Suplemento Alimenticio – 30 Capletas de 850mg

Tainted with the drug ingredients, diclofenac and omeprazole

Announced July 15, 2024 · View FDA announcement

FDA Announcement

American Health Packaging

Potassium Chloride Extended Release 750mg Capsules, 100 count and 500 count

Failed dissolution

Announced June 26, 2024 · View FDA announcement

FDA Announcement

Glenmark Pharmaceuticals, Inc.

Potassium Chloride Extended Release 750mg Capsules, 100 count and 500 count

Failed dissolution

Announced June 25, 2024 · View FDA announcement

FDA Announcement

Suntegrity Skincare

Sunscreen foundation

Higher than acceptable microbiological mold count

Announced June 12, 2024 · View FDA announcement

FDA Announcement

Integrity Products

Dietary Supplements for Male Sexual Enhancement

Product is tainted with sildenafil and tadalafil

Announced June 11, 2024 · View FDA announcement

FDA Announcement

HomeoCare Laboratories Inc.

Homeopathic StellaLife Oral Care Products

Microbial contamination

Announced June 5, 2024 · View FDA announcement

FDA Announcement

Sagent Pharmaceuticals

Docetaxel Injection, USP

Potential presence of particulate matter

Announced May 29, 2024 · View FDA announcement

FDA Announcement

Hospira Inc.

Buprenorphine Hydrochloride Injection Carpuject Units and Labetalol Hydrochloride Injection, USP Carpuject Units

Device & Drug Safety – Potential Packaging Defect

Announced May 22, 2024 · View FDA announcement

FDA Announcement

STOP CLOPEZ CORP

Herbal Dietary Supplement

Product is tainted with Nortadalafil

Announced April 23, 2024 · View FDA announcement

FDA Announcement

Dr. Reddy’s Laboratories Inc

Sapropterin Dihydrochloride Powder for Oral Solution 100 mg

Decreased Potency

Announced April 23, 2024 · View FDA announcement

FDA Announcement

Aruba Aloe Balm N.V.

Hand Sanitizer Gel and Alcoholada Gel

Product contains methanol

Announced April 5, 2024 · View FDA announcement

FDA Announcement

Honeywell Safety Products USA

Non-Sterile Eyewash Cartridge

Non-compliance with current good manufacturing practice (cGMP) requirements.

Announced April 5, 2024 · View FDA announcement

FDA Announcement

AvKARE, LLC

Atovaquone Oral Suspension, USP 750mg/5mL

Potential Bacillus cereus contamination

Announced April 1, 2024 · View FDA announcement

FDA Announcement

Eugia US LLC

Methocarbamol Injection, USP 1000 mg/10 mL (100mg/mL) (Single Dose Vial)

Device & Drug Safety – Presence of Particulate Matter

Announced March 28, 2024 · View FDA announcement

FDA AnnouncementTerminated

Amneal Pharmaceuticals, LLC.

Vancomycin Hydrochloride for Oral Solution, USP, 250 mg/5mL

Super potent due to bottles being overfilled

Announced March 27, 2024 · View FDA announcement

FDA Announcement

Pyramid Wholesale

Dietary supplements for sexual enhancement

Undeclared Sildenafil and/or Tadalafil

Announced March 20, 2024 · View FDA announcement

FDA Announcement

Endo International, Par Pharmaceutical

Treprostinil 20mg/20mL Injection

Potential Presence of Silicone Particulate Matter

Announced March 12, 2024 · View FDA announcement

FDA Announcement

Brassica Pharma Pvt. Ltd.

Eye ointment products

Due to Potential Lack of Sterility Assurance.

Announced February 26, 2024 · View FDA announcement

FDA Announcement

Today the World

Sustain and Schwinnng brand male enhancement capsules

Products contain undeclared Tadalafil and Nortadalafil

Announced February 5, 2024 · View FDA announcement

FDA Announcement

Today the World

Arize brand male enhancement capsules

Products contain undeclared Nortadalafil

Announced February 5, 2024 · View FDA announcement

FDA Announcement

Insight Pharmaceuticals

1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid

Presence of benzene

Announced February 2, 2024 · View FDA announcement

FDA Announcement

Neptune Resources, LLC

Neptune's Fix Elixir, Neptune's Fix Extra Strength Elixir, and Neptune's Fix Tablets

Undeclared Tianeptine

Announced January 29, 2024 · View FDA announcement

FDA AnnouncementTerminated

Azurity Pharmaceuticals, Inc.

dextroamphetamine sulfate tablets, 30 mg

Mislabeled package

Announced January 25, 2024 · View FDA announcement

FDA AnnouncementTerminated

Haleon

Cough syrups

Microbial Contamination

Announced January 24, 2024 · View FDA announcement

FDA Announcement

Kilitch Healthcare India Limited

Lubricant Eye Drops & Multi-Symptom Eye Drops

Device & Drug Safety Potential Safety Concerns

Announced January 22, 2024 · View FDA announcement

FDA Announcement

Leiters Health

Vancomycin IV Bags, Phenylephrine IV Bags, and Fentanyl IV Bags

Potential for superpotent drug

Announced January 8, 2024 · View FDA announcement

FDA Announcement

Kilitch Healthcare India Limited

Lubricant Eye Drops & Multi-Symptom Eye Drops

Device & Drug Safety Potential Safety Concerns

Announced November 15, 2023 · View FDA announcement

FDA AnnouncementTerminated

The Harvard Drug Group, LLC dba Major Pharmaceutical and Rugby Laboratories

OTC Ophthalmic Sterile Drops

Insanitary manufacturing conditions

Announced November 1, 2023 · View FDA announcement

FDA AnnouncementTerminated

KVK-Tech, Inc.

Betaxolol Tablets, USP

Potential Presence of Oxycodone HCl tablet

Announced October 3, 2023 · View FDA announcement

FDA AnnouncementTerminated

Hospira, Inc.

4.2% Sodium Bicarbonate Injection, USP, 1% Lidocaine HCl Injection, USP, and 2% Lidocaine HCl Injection, USP

Potential Presence of Glass Particulates

Announced October 2, 2023 · View FDA announcement

FDA AnnouncementTerminated

VistaPharm

Sucralfate Oral Suspension 1g/10mL

Potential contamination with Bacillus cereus

Announced September 22, 2023 · View FDA announcement

FDA Announcement

Merck Animal Health

Banamine; Banamine-S

Potential presence of particulate matter

Announced September 1, 2023 · View FDA announcement

FDA AnnouncementTerminated

Marlex Pharmaceuticals, Inc.

Digoxin Tablets USP, 0.125mg and 0.25mg

Label Mix-Up

Announced August 31, 2023 · View FDA announcement

FDA AnnouncementTerminated

Lupin Pharmaceuticals, Inc.

Tydemy oral contraceptive

Out of Specification Results

Announced July 31, 2023 · View FDA announcement

FDA AnnouncementTerminated

Cipla

Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation)

Failure to deliver the recommended dose

Announced July 7, 2023 · View FDA announcement

FDA AnnouncementTerminated

The Harvard Drug Group, LLC d/b/a Major Pharmaceutical and Rugby Laboratories

Dronabinol Capsules 2.5mg and Ziprasidone Hydrochloride Capsules 20mg

Packaging may contain incorrect product due to labeling mix-up

Announced June 14, 2023 · View FDA announcement

FDA AnnouncementTerminated

Jarman’s Midwest Cleaning Systems, Inc.

Alcohol Antiseptic 80% Topical Solution Hand Sanitizer Non-sterile Solution; Isopropyl Alcohol Antiseptic 75% Topical Solution Hand Sanitizer Non-sterile Solution

Due to Presence of Methanol

Announced March 28, 2023 · View FDA announcement

FDA AnnouncementTerminated

Volt Candy

PrimeZEN Black 6000 male enhancement capsules

Product contains undeclared tadalafil and sildenafil

Announced February 13, 2023 · View FDA announcement

FDA AnnouncementTerminated

Edgewell Personal Care

Hair & Scalp Spray SPF 30

Due to presence of benzene

Announced January 30, 2023 · View FDA announcement

FDA AnnouncementTerminated

Spectrum Laboratory Products Inc.

Epinephrine bulk API

Product discoloration

Announced January 9, 2023 · View FDA announcement

FDA AnnouncementTerminated

GFA Production

After Burn® Cream and First Aid Kits containing After Burn Cream

Product is contaminated with Bacillus licheniformis and Bacillus sonorensis.

Announced December 27, 2022 · View FDA announcement

FDA AnnouncementTerminated

Lupin Pharmaceuticals Inc.

Quinapril 20 and 40 mg tablets

Presence of nitrosamine impurity, N-Nitroso-Quinapril

Announced December 21, 2022 · View FDA announcement

FDA AnnouncementTerminated

Mylan Institutional LLC, a Viatris company

Octreotide Acetate Injection, 500 mcg/mL

Due to glass particulates

Announced October 25, 2022 · View FDA announcement

FDA AnnouncementTerminated

Golden State Medical Supply, Incorporated

Clopidogrel 75mg Tablets, Atenolol 25mg Tablets

Due to Label Mix-up

Announced September 29, 2022 · View FDA announcement

FDA AnnouncementTerminated

Salon Technologies International Inc.

Ocean Citron Hand Sanitizer

Product contains benzene

Announced September 19, 2022 · View FDA announcement

FDA Announcement

Family Dollar

Toothpaste

Product was stored outside of labeled temperature requirements

Announced September 16, 2022 · View FDA announcement

FDA AnnouncementTerminated

Hospira, Inc., a Pfizer Company

Propofol Injection Emulsion, USP

Potential presence of visible particulate

Announced August 22, 2022 · View FDA announcement

FDA AnnouncementTerminated

Bryant Ranch Prepack Inc.

Morphine Sulfate 30 mg Extended-Release tablets

Incorrect labeling

Announced June 29, 2022 · View FDA announcement

FDA AnnouncementTerminated

Plastikon Healthcare, LLC

Milk of Magnesia, Magnisium Hydroxide/Aluminum Hydroxide/Simethicone Oral Suspension

Due to microbial contamination

Announced June 8, 2022 · View FDA announcement

FDA AnnouncementTerminated

Pfizer

Accupril (Quinapril HCl) tablets 10mg, 20mg, 40 mg

Due to N-Nitroso-Quinapril Content

Announced April 22, 2022 · View FDA announcement

FDA Announcement

Family Dollar, Inc.

Numerous human food, animal (pet) food, medical devices, and drug products

Potential Salmonella contamination and presence of rodent activity at the distribution center

Announced February 18, 2022 · View FDA announcement

FDA AnnouncementTerminated

AuroMedics Pharma LLC

Polymyxin B for Injection USP, 500,000 Units/Vial

Presence of Particulate Matter

Announced January 28, 2022 · View FDA announcement

FDA AnnouncementTerminated

Mylan Pharmaceutical Inc.

Insulin glargine injection), 100 units/ml (U-100), 3mL prefilled pens

Missing Label

Announced January 19, 2022 · View FDA announcement

FDA AnnouncementTerminated

The Proctor & Gamble Company

Old Spice and Secret Aerosol Sprays

Due to the presence of benzene

Announced November 23, 2021 · View FDA announcement

FDA Announcement

Eli Lilly and Company

Glucagon Emergency Kit

Loss of potency

Announced September 26, 2021 · View FDA announcement

FDA Announcement

Pfizer

Varenicline tablets

N-nitroso-varenicline above acceptable daily intake level

Announced September 16, 2021 · View FDA announcement

FDA Announcement

Pfizer

Smoking cessation treatment

N-Nitroso Varenicline content above ADI level

Announced July 19, 2021 · View FDA announcement

FDA Announcement

S&B Shopper LLC

Dietary Supplement for Male Enhancement

Undeclared Sildenafil & Tadalafil

Announced March 25, 2021 · View FDA announcement

FDA AnnouncementTerminated

Precision Dose Inc.

Paroex Chlorhexidine Gluconate Oral Rinse, 15 mL unit dose cups

Potential contamination with Burkholderia lata

Announced December 31, 2020 · View FDA announcement

FDA AnnouncementTerminated

Marksans Pharma Limited

Metformin Hydrochloride for Extended-Release Tablets, USP 500 mg and 750 mg

Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity

Announced October 5, 2020 · View FDA announcement

FDA AnnouncementTerminated

Ashtel Studios

Hand sanitizer packaged in 0.84 oz. pouches

Product is packaged in containers resembling a food and drink pouch

Announced October 2, 2020 · View FDA announcement

FDA Announcement

Estado de México, México, DMM VISSION, S.A. de C.V

Cleaner Hand Sanitizer

Potential Presence of Methanol (Wood Alcohol)

Announced September 30, 2020 · View FDA announcement

FDA AnnouncementTerminated

Sun Pharmaceutical Industries

Metformin Hydrochloride for Extended-Release Oral Suspension

Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity

Announced September 23, 2020 · View FDA announcement

FDA Announcement

Open Book Extracts

Hand Sanitizer

Products labeled to contain methanol

Announced August 31, 2020 · View FDA announcement

FDA Announcement

HARMONIC NATURE S. DE R.L. Mi

Hand sanitizer

Product contains 1 propanol

Announced August 28, 2020 · View FDA announcement

FDA AnnouncementTerminated

Nanomateriales, SA de CV

Hand sanitizer

Product contains 1-propanol.

Announced August 26, 2020 · View FDA announcement

FDA AnnouncementTerminated

Asiaticon SA de CV

Hand Sanitizer

Potential presence of methanol (wood alcohol) and subpotent ethanol levels

Announced August 25, 2020 · View FDA announcement

FDA Announcement

Bayshore Pharmaceuticals, LLC

Metformin Hydrochloride Extended-Release Tablets USP, 500 mg & 750 mg

Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity

Announced August 20, 2020 · View FDA announcement

FDA Announcement

Grupo Asimex de Mexico SA de CV

Antiseptic Hand Sanitizer, 70% Alcohol

Potential Methanol Contamination

Announced August 20, 2020 · View FDA announcement

FDA Announcement

ALBEK de Mexico S.A. de C.V.

Hand Sanitizer

Undeclared Methanol

Announced August 18, 2020 · View FDA announcement

FDA AnnouncementTerminated

Grupo Yacana México S.A.S de C.V.

Yacana Hand Sanitizer, 70% Alcohol

Potential Presence of Methanol (Wood Alcohol) and sub-potent ethanol

Announced August 18, 2020 · View FDA announcement

FDA AnnouncementTerminated

SG24 LLC

All Day Hand Sanitizer

Contains Methanol

Announced August 15, 2020 · View FDA announcement

FDA Announcement

Soluciones Cosmeticas

Hand Sanitizer Gel

Potential Methanol Contamination

Announced August 9, 2020 · View FDA announcement

FDA AnnouncementTerminated

Incredible Products Sa de Cv

Antibacterial Handgel

Methanol Contamination

Announced August 7, 2020 · View FDA announcement

FDA AnnouncementTerminated

Roque Plast S.A. de C.V.

Hand Sanitizer

Methanol Contamination

Announced August 4, 2020 · View FDA announcement

FDA AnnouncementTerminated

Laboratorios Jaloma S.A. de C.V.

Hand Sanitizer

Undeclared Methanol

Announced August 1, 2020 · View FDA announcement

FDA AnnouncementTerminated

Broncolin S.A. de C.V

Hand Sanitizer

Undeclared Methanol

Announced July 28, 2020 · View FDA announcement

FDA Announcement

Resource Recovery & Trading, LLC

Hand Sanitizer

Undeclared Methanol subpotency ethyl alcohol

Announced July 27, 2020 · View FDA announcement

FDA Announcement

4e Brands North America

Hand Sanitizer

Undeclared Methanol

Announced July 27, 2020 · View FDA announcement

FDA AnnouncementTerminated

Maquiladora Miniara, S.A. de C.V.

Hand Sanitizer Gel

Potential presence of methanol (wood alcohol)

Announced July 24, 2020 · View FDA announcement

FDA AnnouncementTerminated

Real Clean Distribuciones SA de CV

Hand Sanitizer

Undeclared methanol

Announced July 24, 2020 · View FDA announcement

FDA AnnouncementTerminated

LIQ-E S.A. de C.V.

Hand Sanitizer

Potential Methanol Contamination

Announced July 20, 2020 · View FDA announcement

FDA AnnouncementTerminated

Soluciones Cosmeticas

Hand Sanitizer Gel

Potential Methanol Contamination

Announced July 14, 2020 · View FDA announcement

FDA AnnouncementTerminated

AAA Cosmetica, S.A. de C.V.

Hand Sanitizer

Potential Undeclared Methanol Contamination

Announced July 14, 2020 · View FDA announcement

FDA Announcement

4e Brands North America

Hand Sanitizer

Undeclared Methanol

Announced July 13, 2020 · View FDA announcement

FDA AnnouncementTerminated

Lupin Pharmaceuticals, Inc.

Metformin Hydrochloride Extended-Release Tablets, 500mg and 1000mg

N-Nitrosodimethylamine (NDMA) Impurity

Announced July 8, 2020 · View FDA announcement

FDA AnnouncementTerminated

ITECH 361

Hand sanitizer

Potential presence of methanol (wood alcohol).

Announced July 6, 2020 · View FDA announcement

FDA AnnouncementTerminated

Transliquid Technologies LLC

Mystic Shield Protection Topical Solution

Undeclared methanol

Announced July 2, 2020 · View FDA announcement

FDA AnnouncementTerminated

UVT, INC.

Advanced Hand Sanitizer, 70% alcohol content

Potential presence of methanol (wood alcohol)

Announced June 29, 2020 · View FDA announcement

FDA Announcement

Saniderm Products

Advanced Hand Sanitizer

May contain methanol (wood alcohol)

Announced June 27, 2020 · View FDA announcement

FDA Announcement

Teva Pharmaceuticals USA Inc.

Metformin Hydrochloride Extended-Release Tablets, USP 500mg and 750mg

Due to detection of N-Nitrosodimethylamine (NDMA)

Announced June 5, 2020 · View FDA announcement

FDA AnnouncementTerminated

GL Holdings

Dietary supplements for male sexual enhancement

Contains Tadalafil

Announced October 22, 2019 · View FDA announcement

FDA AnnouncementTerminated

Teva Pharmaceuticals USA, Inc.

Losartan potassium tablets

Detection of an impurity – N-Nitroso-N-methyl-4-aminobutyric acid (NMBA)

Announced June 11, 2019 · View FDA announcement

FDA Announcement

Vivimed

Losartan Potassium Tablets USP

Due to the detection of N-Nitroso-N-methyl-4-aminobutyric acid (NMBA)

Announced May 3, 2019 · View FDA announcement

FDA Announcement

Asclemed USA Inc dba Envoachem Pharmeceuticals

Dyural-40 and Dyural-80

Due to Latex Hazard

Announced December 17, 2018 · View FDA announcement

FDA Announcement

BD

Vacutainer tubes

Inaccurate lead test results

Announced March 22, 2018 · View FDA announcement

FDA AnnouncementTerminated

Ultra Shop Supplement

Dietary Supplement

Unapproved new drug

Announced February 8, 2018 · View FDA announcement

FDA Announcement

Kiriko, LLC

Dietary Supplement A1 Slim

Unapproved new drug; tainted with sibutramine, phenolphthalein and N-Desmethyl sibutramine

Announced October 19, 2017 · View FDA announcement

Filters
Recall details
Location
Date range
Clear filters

Showing 1–20 of 18,009 drug recalls

Drug Recall Ongoing 2026 recordClass II

Benzoyl Peroxide Wash, USP, 10%, packaged in a)5 FL OZ (148mL) bottles (NDC 0536-1261-63), and b) 8.5 FL OZ (237 mL) bottles (NDC 0536-1351-42), Distributed by: Rugby Laboratories, 17177 N. Laurel Park Drive, Suite 233, Livonia, MI 48152.

by SV Labs Toronto Corporation

Reason
Microbial contamination of topical product.
Recall initiated
September 1, 2026
Reported by FDA
October 7, 2026
Distribution
IL only

View recall →

Drug Recall Ongoing 2026 recordClass II

Benzoyl Peroxide Wash, USP, 5%, 5 FL OZ (148 mL), Distributed by: Rugby Laboratories, 17177 N. Laurel Park Drive, Suite 233, Livonia, MI 48152. NDC: 0536-1259-63

by SV Labs Toronto Corporation

Reason
Microbial contamination of topical product.
Recall initiated
September 1, 2026
Reported by FDA
October 7, 2026
Distribution
IL only

View recall →

Drug Recall Ongoing 2026 recordClass II

Paroxetine Extended-Release Tablets, 37.5mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for: Apotex Corp., Weston, Florida 33326, NDC 60505-1318-3

by Apotex Corp.

Reason
Failed dissolution specifications.
Recall initiated
September 23, 2026
Reported by FDA
October 7, 2026
Distribution
US Nationwide.

View recall →

Drug Recall Ongoing 2026 recordClass II

Buprenorphine Hydrochloride, Injection 0.3 mg/mL, Rx Only, 5 x 1 mL Single Dose Vials, Manufactured for: Endo USA, Malvern, PA, NDC 42023-179-05

by Par Health USA, LLC

Reason
Crystallization
Recall initiated
September 8, 2026
Reported by FDA
October 7, 2026
Distribution
U.S. Nationwide

View recall →

Drug Recall Ongoing 2026 recordClass II

Zoladex (goserelin) implant, 3.6 mg, One single-Use Syringe packaged in a carton, Rx only, Manufactured for: TerSera therapeutics LLC, Deerfield, IL 60015, BY: AstraZeneca UK Limited, Macclesfield, England, Product of Switzerland, website at www.zoladex.com, NDC 70720-950-36.

by TerSera Therapeutics LLC

Reason
Temperature Abuse: Product sat in a non-temperature-controlled FedEx trailer at ambient outdoor conditions for 25.5 hours.
Recall initiated
August 31, 2026
Reported by FDA
October 7, 2026
Distribution
USA Nationwide

View recall →

Drug Recall Ongoing 2026 recordClass II

FOCUS PI Hypromellose 0.7% Formula, 0.3 FL O (10 mL) per vial, STERILE, Manufactured for: Covalent Management, Inc., Manassas, VA 20109. NDC: 82724-007-19

by Aurolab Trust

Reason
Lack of Assurance of Sterility
Recall initiated
September 17, 2026
Reported by FDA
October 7, 2026
Distribution
VA

View recall →

Drug Recall Ongoing 2026 recordClass II

Estradiol Gel, 0.1%, 0.25 mg, 30-packets per carton, Rx only, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08907, NDC 69238-2452-3.

by Amneal Pharmaceuticals, LLC

Reason
Defective Container; packets were found to be either empty or partially full.
Recall initiated
September 8, 2026
Reported by FDA
October 7, 2026
Distribution
Nationwide in the USA.

View recall →

Drug Recall Ongoing 2026 recordClass II

Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807. NDC: 27241-126-02

by Ajanta Pharma USA Inc

Reason
Failed Dissolution Specifications: below specification
Recall initiated
September 17, 2026
Reported by FDA
October 7, 2026
Distribution
Nationwide in the US.

View recall →

Drug Recall Ongoing 2026 recordClass II

Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) with Hang Tag, 0.5 fl oz (15mL) per dropper bottle, STERILE, Dist. by Medtech Products Inc., Tarrytown, NY 10591. NDC: 67172-797-15

by Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company

Reason
Lack of Assurance of Sterility
Recall initiated
September 15, 2026
Reported by FDA
September 30, 2026
Distribution
Nationwide in the USA.

View recall →

Drug Recall Ongoing 2026 recordClass II

Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) , 0.5 fl oz (15mL) per dropper bottle, STERILE, Dist. by Medtech Products Inc., Tarrytown, NY 10591. NDC: 67172-797-15

by Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company

Reason
Lack of Assurance of Sterility
Recall initiated
September 15, 2026
Reported by FDA
September 30, 2026
Distribution
Nationwide in the USA.

View recall →

Drug Recall Ongoing 2026 recordClass II

Exenatide Injection, USP, 250 mcg/mL, 1.2 mL per prefilled pen, Rx Only, Subcutaneous Use Only, For Single Patient Use Only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad 382213, India; Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 70121-1685-1

by Amneal Pharmaceuticals of New York, LLC

Reason
Defective Delivery System: Possibility of no medication in the prefilled pen.
Recall initiated
August 28, 2026
Reported by FDA
September 30, 2026
Distribution
USA Nationwide

View recall →

Drug Recall Ongoing 2026 recordClass III

Olanzapine Tablets, USP 5 mg, 30-count bottle, Rx Only, Manufactured For: Macleods Pharma USA, Inc. Princeton, NJ, 08540; Manufactured by: Macleods Pharmaceuticals, Ltd, Baddi, Himachal Pradesh, INDIA, NDC 33342-068-07.

by Macleods Pharmaceuticals Limited

Reason
Failed Impurities/Degradation Specifications:Organic and unspecified impurities above specification.
Recall initiated
August 27, 2026
Reported by FDA
September 30, 2026
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing 2026 recordClass II

AvKare Carboxymethylcellulose Sodium Ophthalmic Solution 0.5%, Lubricant Eye Drops, Sterile, 0.5 FL OZ (15 mL) EACH, 1.0 FL OZ (30 mL) TOTAL, 2 count Twin Pack, Distributed by: AVKARE, Pulaski, TN, 38478, NDC 50268-068-02 (carton)

by Sterling Pharmaceutical Services LLC

Reason
Lack of Assurance of Sterility
Recall initiated
August 20, 2026
Reported by FDA
September 30, 2026
Distribution
USA Nationwide

View recall →

Drug Recall Ongoing 2026 recordClass II

Lubricant Eye Drops-Cameron Pharmaceuticals, Carboxymethylcellulose Sodium 0.5%, Eye Lubricant, 0.5 FL OZ (15 mL) bottles, Distributed by Cameron Pharmaceuticals, LLC, Louisville, KY, 40245, NDC 42494-448-05

by Sterling Pharmaceutical Services LLC

Reason
Lack of Assurance of Sterility
Recall initiated
August 20, 2026
Reported by FDA
September 30, 2026
Distribution
USA Nationwide

View recall →

Drug Recall Ongoing 2026 recordClass II

Major LubriFresh P.M. Nighttime Ointment, Net wt. 0.125 oz. (3.5 g) tubes, Distributed by: Major Pharmaceuticals, 17177 N Laurel Park Drive, Suite 233, Livonia, MI 48152, NDC 0904-6488-38

by Sterling Pharmaceutical Services LLC

Reason
Lack of Assurance of Sterility
Recall initiated
August 20, 2026
Reported by FDA
September 30, 2026
Distribution
USA Nationwide

View recall →

Drug Recall Ongoing 2026 recordClass II

TRP The Relief Products* Gentle Eyes Lubricant Eye Drops, Carboxymethylcellulose sodium 0.5%, Sterile Eye Drops, 0.5 FL OZ (15 mL) bottles, Manufactured exclusively for TRP Company, Inc. 1575 Delucci Ln, Reno, NV 89502, NDC 17312-430-15.

by Sterling Pharmaceutical Services LLC

Reason
Lack of Assurance of Sterility
Recall initiated
August 20, 2026
Reported by FDA
September 30, 2026
Distribution
USA Nationwide

View recall →

Drug Recall Ongoing 2026 recordClass II

Reliable-1 Laboratories Lubricating Tears, Sterile, 0.5 FL OZ (15 mL) bottles, Distributed by: Reliable-1 Laboratories LLC, Valley Stream, NY, 11580, www.reliable1labs.com, NDC 69618-076-55.

by Sterling Pharmaceutical Services LLC

Reason
Lack of Assurance of Sterility
Recall initiated
August 20, 2026
Reported by FDA
September 30, 2026
Distribution
USA Nationwide

View recall →

Drug Recall Ongoing 2026 recordClass II

Walgreens Lubricant Eye Drops, 0.5 FL OZ (15 mL) 1.0 FL OZ (30 mL) TOTAL, 2 count Twin Pack, Distributed by Walgreens Co., 200 Wilmot Road, Deerfield, IL 60015, NDC 0363-8833-15.

by Sterling Pharmaceutical Services LLC

Reason
Lack of Assurance of Sterility
Recall initiated
August 20, 2026
Reported by FDA
September 30, 2026
Distribution
USA Nationwide

View recall →

Drug Recall Ongoing 2026 recordClass II

Walgreens Lubricant Eye Drops, Carboxymethylcellulose sodium 0.5%, Lubricant Eye Drops, Sterile, 0.5 OZ (15 mL) bottles, Distributed by Walgreen Co., 200 Wilmot Rd., Deerfield, IL 60015, NDC 0363-8833-15.

by Sterling Pharmaceutical Services LLC

Reason
Lack of Assurance of Sterility
Recall initiated
August 20, 2026
Reported by FDA
September 30, 2026
Distribution
USA Nationwide

View recall →

Drug Recall Ongoing 2026 recordClass II

Reliable -1 Laboratories, Sodium Chloride Hypertonicity Ophthalmic Solution, 5%, Sterile, 0.5 FL OZ (15 mL) bottles, Distributed by: Reliable-1 Laboratories LLC, Valley Stream, NY, 11580, NDC 69618-077-55.

by Sterling Pharmaceutical Services LLC

Reason
Lack of Assurance of Sterility
Recall initiated
August 20, 2026
Reported by FDA
September 30, 2026
Distribution
USA Nationwide

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.